Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Francis McDermott, M.D.

Concepts (410)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with David McDermott's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that David McDermott has written about over time.
Interferon-alpha, 13 publications between 2002 and 2018, average publication date February 2009. Interleukin-2, 35 publications between 2002 and 2019, average publication date April 2010. Antineoplastic Agents, 62 publications between 2004 and 2021, average publication date January 2013. Phenylurea Compounds, 15 publications between 2008 and 2021, average publication date February 2013. Vascular Endothelial Growth Factor A, 26 publications between 2007 and 2022, average publication date May 2014. Antibodies, Monoclonal, 49 publications between 2007 and 2019, average publication date October 2014. Kidney Neoplasms, 142 publications between 2003 and 2022, average publication date December 2014. Carcinoma, Renal Cell, 149 publications between 2003 and 2022, average publication date January 2015. Melanoma, 58 publications between 2002 and 2022, average publication date January 2015. Immunotherapy, 40 publications between 2005 and 2022, average publication date April 2015. Antineoplastic Combined Chemotherapy Protocols, 70 publications between 2002 and 2022, average publication date June 2016.

To see the data from this visualization as text, click here.
McDermott's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (410)
Explore
_
Co-Authors (121)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.